Mary Fowkes

[1][2] Her findings that victims had suffered multiple organ failures resulted in the recommendation for use of blood thinners as a part of the treatment process.

She joined the Icahn School of Medicine at Mount Sinai Hospital in Manhattan as an assistant professor of pathology and went on to become the director of neuropathology.

[4] The findings from autopsies performed by Fowkes and her team led to the increased use of blood thinners as a part of the treatment process, resulting in improved responses in many patients.

[5] The New York Times noted that working with oscillating saws to open the skulls of COVID-19 victims during autopsies, in order to remove the brain, potentially exposed her to the virus through aerosolized fragments of the bone and droplets of blood.

[1] In a conversation with the BBC World Service, Fowkes reinforced the importance of performing these autopsies despite the risks posed to the operating physicians.